1 Day
Source:
New York Post
New York Post
Ready to play
Ready to play
A recent case highlights concerns over AlloClae, a non-surgical breast enhancement product made from donor-derived fat, which debuted in the US in 2024. Users have reported complications such as lumps, cysts, and pain, with some experiencing lasting tissue damage. The product is under legal dispute in New York, where regulators allege improper distribution, while medical professionals warn about risks like fat necrosis, though official safety data remains limited.
Notice: This Is an AI-Generated Summary
Comments (0)